EPIX In $28M Deal To Develop Contrast Agents With Schering May 28, 2003 By Aaron Lorenzo EPIX Medical Inc. is returning to a familiar partner, Schering AG, to develop contrast agents for use in MRI in a deal that could garner up to $28 million in near-term money for EPIX.(BioWorld Today)Read More
Inspire's Intranasal Drug Fails To Hit Endpoint In Allergic Rhinitis May 21, 2003 By Aaron Lorenzo Inspire Pharmaceuticals Inc. reported less-than-rousing results from a Phase III trial in allergic rhinitis. (BioWorld Today)Read More
